Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $175.97 Million |
|---|---|
| Enterprise Value | $5.15 Billion |
| Earnings per Share | $0 |
| Beta | 0 |
| Outstanding Shares | 0 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.79 |
| Enterprise Value to EBIT | 2.3 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0.97 |
| Debt to Equity | 0.49 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
City Therapeutics, Inc. is a biotechnology company specializing in next-generation RNA interference (RNAi) therapeutics. The company is based in Cambridge, MA. The company engineers potent, specific, and durable RNAi trigger molecules co...